{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:49:50Z","timestamp":1791650990242,"version":"4.3.4"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.arr.2026.103366","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:11:30Z","timestamp":1789024290000},"page":"103366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sociodemographic and clinical characteristics of participants in blood p-tau217 studies for Alzheimer\u2019s disease: A systematic review"],"prefix":"10.1016","volume":"122","author":[{"given":"Marco","family":"Toccaceli Blasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4319-0740","authenticated-orcid":false,"given":"Simona","family":"Buscarnera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7805-5173","authenticated-orcid":false,"given":"Martina","family":"Salzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2993-569X","authenticated-orcid":false,"given":"Marc","family":"Su\u00e1rez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9797-1422","authenticated-orcid":false,"given":"Gianmarco","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Valletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Rune","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-162X","authenticated-orcid":false,"given":"Anja Hviid","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Nuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-7169","authenticated-orcid":false,"given":"Giuseppe","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9955-8220","authenticated-orcid":false,"given":"Daniel","family":"Kjaergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7333-6478","authenticated-orcid":false,"given":"Marco","family":"Canevelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103366_bib1","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"(KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.arr.2026.103366_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106864","article-title":"Associations between air pollution and biomarkers of Alzheimer\u2019s disease in cognitively unimpaired individuals","volume":"157","author":"Alemany","year":"2021","journal-title":"Environ. Int."},{"key":"10.1016\/j.arr.2026.103366_bib3","series-title":"Overcoming ethical challenges affecting the involvement of people with dementia in research: recognising diversity and promoting inclusive research","author":"Alzheimer Europe","year":"2019"},{"key":"10.1016\/j.arr.2026.103366_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14609","article-title":"A head-to-head comparison of plasma biomarkers to detect Alzheimer\u2019s disease in a memory clinic","volume":"21","author":"Anastasi","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13195-024-01513-9","article-title":"Diagnostic performance of plasma pTau217, pTau181, A\u03b21-42 and A\u03b21-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease","volume":"16","author":"Arranz","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103366_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13195-025-01692-z","article-title":"The impact of kidney function on Alzheimer\u2019s disease blood biomarkers: implications for predicting amyloid-\u03b2 positivity","volume":"17","author":"Arslan","year":"2025","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103366_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib8","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103366_bib9","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s00259-021-05253-y","article-title":"The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers","volume":"48","author":"Ashton","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2026.103366_bib10","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/alz.12841","article-title":"Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays","volume":"19","author":"Ashton","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib11","article-title":"Plasma p-tau217 concordance with amyloid PET among ethnically diverse older adults","volume":"16","author":"Asken","year":"2024","journal-title":"Alzheimers Dement. (Amst. )"},{"key":"10.1016\/j.arr.2026.103366_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3233\/JAD-200282","article-title":"Heavy Metals Exposure and Alzheimer\u2019s Disease and Related Dementias","volume":"76","author":"Bakulski","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jamaneurol.2018.3444","article-title":"Biomarkers for Alzheimer Dementia in Diverse Racial and Ethnic Minorities-A Public Health Priority","volume":"76","author":"Barnes","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1377\/hlthaff.2013.1353","article-title":"Alzheimer\u2019s disease in African Americans: risk factors and challenges for the future","volume":"33","author":"Barnes","year":"2014","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.arr.2026.103366_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer\u2019s disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103366_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068005","article-title":"Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study","volume":"376","author":"Ben Hassen","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.arr.2026.103366_bib17","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/01.WNL.0000069923.64550.9F","article-title":"Education modifies the relation of AD pathology to level of cognitive function in older persons","volume":"60","author":"Bennett","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103366_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210287","article-title":"Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations","volume":"104","author":"Bornhorst","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103366_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMms2029562","article-title":"Race and Genetic Ancestry in Medicine - A Time for Reckoning with Racism","volume":"384","author":"Borrell","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103366_bib20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer\u2019s disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/acn3.51529","article-title":"Correlation of plasma and neuroimaging biomarkers in Alzheimer\u2019s disease","volume":"9","author":"Brickman","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamaneurol.2023.4719","article-title":"Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial","volume":"81","author":"Brum","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-014-0192-4","article-title":"Comorbidity and dementia: a scoping review of the literature","volume":"12","author":"Bunn","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.arr.2026.103366_bib24","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1007\/s11357-025-01547-3","article-title":"Unraveling the link between frailty and Alzheimer\u2019s disease biomarkers in patients with mild cognitive impairment","volume":"47","author":"Buscarnera","year":"2025","journal-title":"GeroScience"},{"key":"10.1016\/j.arr.2026.103366_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.32124","article-title":"Association of Multimorbidity, Disease Clusters, and Modification by Genetic Factors With Risk of Dementia","volume":"5","author":"Calvin","year":"2022","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.arr.2026.103366_bib26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11357-020-00293-y","article-title":"Biomarkers and phenotypic expression in Alzheimer\u2019s disease: exploring the contribution of frailty in the Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"43","author":"Canevelli","year":"2021","journal-title":"GeroScience"},{"key":"10.1016\/j.arr.2026.103366_bib27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3233\/JAD-231114","article-title":"The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer\u2019s Disease","volume":"98","author":"Cao","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib28","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1007\/s00415-024-12631-7","article-title":"Diagnostic accuracy of automated Lumipulse plasma pTau-217 in Alzheimer\u2019s disease: a real-world study","volume":"271","author":"Cecchetti","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib29","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/ckj\/sfad173","article-title":"Plasma A\u03b242:A\u03b240 ratio as a biomarker for cognitive impairment in haemodialysis patients: a multicentre study","volume":"16","author":"Chen","year":"2023","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.arr.2026.103366_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14502","article-title":"Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease","volume":"21","author":"Chong","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14629","article-title":"Plasma Alzheimer\u2019s disease biomarker relationships with incident abnormal amyloid PET","volume":"21","author":"Cogswell","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib32","article-title":"Blood-based biomarkers in the oldest old: towards Alzheimer\u2019s disease detection in primary care","volume":"45","author":"Contador","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.arr.2026.103366_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41398-024-03084-7","article-title":"P-tau217 and other blood biomarkers of dementia: variation with time of day","volume":"14","author":"della Monica","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2026.103366_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad333","article-title":"Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors","volume":"5","author":"Du","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2026.103366_bib35","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1002\/alz.14100","article-title":"Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer\u2019s risk-enhanced sample","volume":"20","author":"Du","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/alz.12433","article-title":"Diversity in Alzheimer\u2019s disease drug trials: The importance of eligibility criteria","volume":"18","author":"Franzen","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib37","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214446","article-title":"Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Community-Dwelling Older Adults","volume":"106","author":"Gasparini","year":"2026","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103366_bib38","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public. Health"},{"key":"10.1016\/j.arr.2026.103366_bib39","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.trci.2019.09.018","article-title":"Recruitment and retention of underrepresented populations in Alzheimer\u2019s disease research: A systematic review","volume":"5","author":"Gilmore-Bykovskyi","year":"2019","journal-title":"Alzheimers Dement. (N. Y)"},{"key":"10.1016\/j.arr.2026.103366_bib40","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/alz.12511","article-title":"Alzheimer\u2019s disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence","volume":"18","author":"Gleason","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105741","article-title":"A plasma biomarker panel for detecting early amyloid-\u03b2 accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer\u2019s disease","volume":"116","author":"Gonz\u00e1lez-Escalante","year":"2025","journal-title":"eBioMedicine"},{"key":"10.1016\/j.arr.2026.103366_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.arr.2026.103366_bib43","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamapsychiatry.2022.3446","article-title":"Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia","volume":"79","author":"Guo","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.arr.2026.103366_bib44","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103366_bib45","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1136\/jnnp-2024-334122","article-title":"How well do plasma Alzheimer\u2019s disease biomarkers reflect the CSF amyloid status?","volume":"96","author":"Hazan","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2026.103366_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70066","article-title":"Plasma Phosphorylated Tau 217 as a Discriminative Biomarker for Cerebral Amyloid Angiopathy","volume":"32","author":"Hsieh","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib48","article-title":"The Taiwan-ADNI workflow toward integrating plasma p-tau217 into prediction models for the risk of Alzheimer\u2019s disease and tau burden","volume":"21","author":"Huang","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-170242","article-title":"Challenges and Considerations Related to Studying Dementia in Blacks\/African Americans","volume":"60","author":"Ighodaro","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib50","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib51","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/brain\/awad042","article-title":"Predicting amyloid PET and tau PET stages with plasma biomarkers","volume":"146","author":"Jack","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103366_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70765","article-title":"Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer\u2019s disease","volume":"21","author":"Jacobs","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib53","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awac333","article-title":"Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease","volume":"146","author":"Janelidze","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103366_bib54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","article-title":"Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios","volume":"80","author":"Janelidze","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib55","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1038\/s41598-024-59530-5","article-title":"Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment","volume":"14","author":"Jing","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2026.103366_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14458","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer\u2019s disease pathology among cognitively impaired and unimpaired: A systematic review and meta-analysis","volume":"21","author":"Khalafi","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2026.126057","article-title":"Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort","volume":"488","author":"Kjaergaard","year":"2026","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103366_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70315","article-title":"Influence of ethnicity on the diagnostic accuracy of plasma p-tau217 for the identification of Alzheimer\u2019s disease: A consecutive mixed memory clinic cohort study","volume":"21","author":"Kjaergaard","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2025.123739","article-title":"Combining plasma p-tau217 and cross-cultural cognitive tests to identify Alzheimer\u2019s Disease in an ethnically diverse mixed memory clinic cohort","volume":"478","author":"Kjaergaard","year":"2025","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.arr.2026.103366_bib60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/13872877241299047","article-title":"Ethnic and racial influences on blood biomarkers for Alzheimer\u2019s disease: A systematic review","volume":"103","author":"Kjaergaard","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib61","article-title":"Plasma Alzheimer\u2019s disease biomarker variability: Amyloid-independent and amyloid-dependent factors","volume":"21","author":"Lee","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib62","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/jnnp-2024-333467","article-title":"Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment","volume":"95","author":"Lehmann","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2026.103366_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100092","article-title":"Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimer\u02bcs disease in a Chinese cohort","volume":"12","author":"Li","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib64","article-title":"Cross-cultural validation of plasma p-tau217 and p-tau181 as precision biomarkers for amyloid PET positivity: An East Asian study in Taiwan and Korea","volume":"21","author":"Lin","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70411","article-title":"Multimorbidity patterns and blood biomarkers of Alzheimer\u2019s disease in community-dwelling cognitively unimpaired older adults","volume":"21","author":"Marengoni","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib66","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.14283\/jpad.2024.152","article-title":"Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform","volume":"11","author":"Mart\u00ednez-Dubarbie","year":"2024","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib67","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/brain\/awaa286","article-title":"Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease","volume":"143","author":"Mattsson-Carlgren","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103366_bib68","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jalz.2015.12.007","article-title":"Inequalities in dementia incidence between six racial and ethnic groups over 14 years","volume":"12","author":"Mayeda","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib69","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3233\/JAD-220158","article-title":"Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds","volume":"87","author":"McCarter","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jalz.2016.06.2360","article-title":"Systematic review of dementia prevalence and incidence in United States race\/ethnic populations","volume":"13","author":"Mehta","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib71","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","article-title":"Performance of plasma phosphorylated tau 181 and 217 in the community","volume":"28","author":"Mielke","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103366_bib72","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41582-024-00989-1","article-title":"Alzheimer disease blood biomarkers: considerations for population-level use","volume":"20","author":"Mielke","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib73","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/alz.12823","article-title":"Improving generalizability and study design of Alzheimer\u2019s disease cohort studies in the United States by including under-represented populations","volume":"19","author":"Mindt","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS. Med."},{"key":"10.1016\/j.arr.2026.103366_bib75","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1002\/alz.13722","article-title":"The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer\u2019s disease","volume":"20","author":"Mohs","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13195-023-01302-w","article-title":"Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment","volume":"15","author":"Mundada","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103366_bib77","unstructured":"National Institutes of Health, 2001. NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research."},{"key":"10.1016\/j.arr.2026.103366_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14585","article-title":"Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts","volume":"21","author":"Nayyar","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","article-title":"Combining plasma A\u03b2 and p-tau217 improves detection of brain amyloid in non-demented elderly","volume":"16","author":"Niimi","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2026.103366_bib80","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41593-025-02000-6","article-title":"Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-\u03b2 status, APOE genotype and sex","volume":"28","author":"Ossenkoppele","year":"2025","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103366_bib81","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2026.103366_bib82","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2026.103366_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-019-0917-z","article-title":"Defining Cognitive Reserve and Implications for Cognitive Aging","volume":"19","author":"Pettigrew","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2026.103366_bib84","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib85","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/awae368","article-title":"Plasma p-tau217 in Alzheimer\u2019s disease: Lumipulse and ALZpath SIMOA head-to-head comparison","volume":"148","author":"Pilotto","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103366_bib86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-244X-14-84","article-title":"Comorbidity of dementia: a cross-sectional study of primary care older patients","volume":"14","author":"Poblador-Plou","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.arr.2026.103366_bib87","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jgs.16244","article-title":"Medical Comorbidities of Dementia: Links to Caregivers\u2019 Emotional Difficulties and Gains","volume":"68","author":"Polenick","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2026.103366_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14406","article-title":"Visual read of [F-18]florquinitau PET that includes and extends beyond the mesial temporal lobe is associated with increased plasma pTau217 and cognitive decline in a cohort that is enriched with risk for Alzheimer\u2019s disease","volume":"21","author":"Rea Reyes","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70426","article-title":"Evaluation of plasma p-tau217 for detecting amyloid pathology in a heterogeneous community-based cohort","volume":"21","author":"Rudolph","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib90","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/alz.13454","article-title":"Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults","volume":"20","author":"Saloner","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib91","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/153331750201700210","article-title":"Co-morbidity associated with dementia","volume":"17","author":"Sanderson","year":"2002","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"10.1016\/j.arr.2026.103366_bib92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00415-025-12897-5","article-title":"Accuracy and clinical applicability of plasma tau 181 and 217 for Alzheimer\u2019s disease diagnosis in a memory clinic cohort","volume":"272","author":"Sarto","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib93","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer\u2019s disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.07.013","article-title":"Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease","volume":"5","author":"Sch\u00f6ll","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.arr.2026.103366_bib95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1532-5415.2005.00543.x","article-title":"Comorbidity profile of dementia patients in primary care: are they sicker?","volume":"54","author":"Schubert","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2026.103366_bib96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/JAD-150778","article-title":"A Meta-Analysis of Alzheimer\u2019s Disease Incidence and Prevalence Comparing African-Americans and Caucasians","volume":"50","author":"Steenland","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib97","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70546","article-title":"Multimorbidity in dementia: Current perspectives and future challenges","volume":"21","author":"Stirland","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib99","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.56.1.49","article-title":"Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan","volume":"56","author":"Tang","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103366_bib100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib101","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1002\/alz.14138","article-title":"The Bayesian approach for real-world implementation of plasma p-tau217 in tertiary care memory clinics in Thailand","volume":"20","author":"Thanapornsangsuth","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib102","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","article-title":"Blood phosphorylated tau for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"24","author":"Therriault","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib103","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s43587-024-00731-y","article-title":"Diagnosis of Alzheimer\u2019s disease using plasma biomarkers adjusted to clinical probability","volume":"4","author":"Therriault","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2026.103366_bib104","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1002\/alz.13026","article-title":"Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer\u2019s disease","volume":"19","author":"Therriault","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib106","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2026.4029","article-title":"Anemia and Blood Biomarkers of Alzheimer Disease in Dementia Development","volume":"9","author":"Valletta","year":"2026","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.arr.2026.103366_bib107","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1002\/alz.13860","article-title":"Blood biomarkers of Alzheimer\u2019s disease in the community: Variation by chronic diseases and inflammatory status","volume":"20","author":"Valletta","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib108","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaneurol.2024.2801","article-title":"Blood-Based Biomarkers for Alzheimer Disease\u2014Ready for Primary Care?","volume":"81","author":"VandeVrede","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib109","doi-asserted-by":"crossref","first-page":"e3269","DOI":"10.1212\/WNL.0000000000010944","article-title":"Neuropathologic burden and the degree of frailty in relation to global cognition and dementia","volume":"95","author":"Wallace","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103366_bib110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(18)30371-5","article-title":"Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer\u2019s disease: a cross-sectional analysis of data from the Rush Memory and Aging Project","volume":"18","author":"Wallace","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib111","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/brain\/awae346","article-title":"A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests","volume":"148","author":"Warmenhoven","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.arr.2026.103366_bib112","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/13872877241309105","article-title":"Differences of longitudinal plasma biomarkers between single memory domain and multidomain subjective cognitive decline: Evidence from SILCODE","volume":"103","author":"Wei","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2026.103366_bib113","article-title":"Plasma p-tau217, p-tau181, and NfL as early indicators of dementia risk in a community cohort: The Shanghai Aging Study","volume":"15","author":"Xiao","year":"2023","journal-title":"Alzheimers Dement. (Amst. )"},{"key":"10.1016\/j.arr.2026.103366_bib114","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1002\/alz.14178","article-title":"Significance of plasma p-tau217 in predicting long-term dementia risk in older community residents: Insights from machine learning approaches","volume":"20","author":"Xiao","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2026.103366_bib115","doi-asserted-by":"crossref","first-page":"e2956","DOI":"10.1212\/WNL.0000000000012113","article-title":"Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older Adults: A Registry-Based Study","volume":"96","author":"Xu","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2026.103366_bib116","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.gerinurse.2024.07.005","article-title":"Association between polypharmacy and cognitive impairment in older adults: A systematic review and meta-analysis","volume":"59","author":"Yu","year":"2024","journal-title":"Geriatr. Nurs."},{"key":"10.1016\/j.arr.2026.103366_bib117","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamaneurol.2024.5263","article-title":"Temporal Dynamics and Biological Variability of Alzheimer Biomarkers","volume":"82","author":"Yun","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2026.103366_bib118","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1037\/neu0000720","article-title":"Socioeconomic and psychosocial mechanisms underlying racial\/ethnic disparities in cognition among older adults","volume":"35","author":"Zahodne","year":"2021","journal-title":"Neuropsychology"},{"key":"10.1016\/j.arr.2026.103366_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14536","article-title":"Plasma p-tau217 and p-tau217\/A\u03b21-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer\u2019s disease: Insights for research and clinical practice","volume":"21","author":"Zhong","year":"2025","journal-title":"Alzheimers Dement."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726003582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:59:21Z","timestamp":1791647961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726003582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":119,"alternative-id":["S1568163726003582"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103366","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sociodemographic and clinical characteristics of participants in blood p-tau217 studies for Alzheimer\u2019s disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103366"}}